ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Ziling Zheng, Maocai Tang, Shouru Zhang, Hao Sun, Jingkun Shang
Objective: To investigate the short-term efficacy of laparoscopic radical resection of right-sided colon cancer with two different surgeon positions and trocar placements. Methods: The data of 78 patients who underwent laparoscopic radical resection of right-…
Snany Surendran, Radha Devi, Raktim Chattopadhyay, Anubhab Mukherjee, Shrikant Charde
Cancer patients develop cachexia due to systemic inflammation, negative p rotein and energy balance. Esperer Onco Nutrition (EON) has come up with innovative nutritional supplements (EON Therapy) that help patients take the rigours of cancer therapy thereby i…
Sidy Ka, Yaméogo Bonaventure, Mamadou M. Dieng, Souleymane Dieng, Jaafar Thiam, Salif Baldé, Ahmadou Dem
Background: Surgery is the treatment for early-stage cervical cancer. Radiochemotherapy is used in the treatment of locally advanced stages. But the choice of treatment can be difficult. Objective: The objective of this work was to evaluate the therapeutic as…
Iriss A. Darar, Zakari Saye, Bourama Diarra, Madiassa Konaté, Amadou Traoré, Seydou Pamateck, Abdillahi I. Ismail, Arouna Adama Doumbia, Boubacar Karembé, Bakary Tientigui Dembélé, Lassana Kanté, Drissa Traoré, Zimogo Zié Sanogo, Alhassane Traoré, Adégné Togo
Introduction: Male breast cancer is rare; representing 1% of breast cancers and less than 1% of all male neoplasia worldwide. We here analyzed the clin ical, histological, therapeutic and prognostic characteristics of male breast cancer in Bamako, Mali. Patie…
Kirsten H. Walen
Normal cells must become cancer-enabling before anything else occurs, according to latest literature. The goal in this mini-review is to demonstrate special tetraploidy in the enabling process. This we have shown from genomic damage, DDR (DNA Damage Response)…
Jeanine Staples, Varvara Mazina, Bethany-Rose Daubman, Annekathryn Goodman
Introduction: The decision to stop anti-cancer treatment is fraught with many challenges for the oncologist, the patient, and their caregivers. This review examines the special considerations surrounding the decision to cease chemotherapy in terminally ill ca…
E. Russell Vickers
Gamma radiation exposure and physical inactivity occur in medical radiotherapy patients and astronauts resulting in substantial deterioration of their health. At the molecular level, the radiation triggers elevated markers for DNA double-strand breaks and tum…
Dianbin Song, Zhiyong Wang, Xiuming Li, Jingjing Zhang, Qiang Chi, Hui Xu, Hongyang Li, Ying Liu
Objective: T he objective is to explore the effects of different surgical methods-retroperitoneal laparoscopic radical nephrectomy (RLRN) and open radical nephrectomy (ORN) on the number of circulating tumor cells (CTC) in the peripheral blood of patients wit…
Changliang Jiao, Cheng Yang, Xingjun Tan, Min Guo, Xiaoxin Gao, Juncheng Guo
MicroRNA (miRNA) is a class of endogenous non-coding and regulatory single stranded small RNA molecules, about 18 - 24 nucleotides in length. More than 800 miRNA coding genes have been identified in the human genome, and about 113 target genes are predicted t…
Aravindh Sivanandan Anand, Abul Hussain Mirsa, Amina Basheer
Background: Treatment options available for breast cancer are Surgery [Breast conservation surgery (BCS) or Modified radical mastectomy (MRM)]; Radiation treatment [Conventional radiation treatment or CRT and Hypofractionated radiation treatment or HRT] and C…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).